249 related articles for article (PubMed ID: 32035930)
1. A systematical comparison of anti-angiogenesis and anti-cancer efficacy of ramucirumab, apatinib, regorafenib and cabozantinib in zebrafish model.
Wu JQ; Fan RY; Zhang SR; Li CY; Shen LZ; Wei P; He ZH; He MF
Life Sci; 2020 Apr; 247():117402. PubMed ID: 32035930
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel and 5-FU enhanced the inhibitory effects of apatinib and ramucirumab on growth and migration of gastric cancer.
Wu JQ; Fan RY; Zhai J; Li CY; Wei P; Shen LZ; He MF; Wang P; Huang XE
Life Sci; 2022 May; 296():120439. PubMed ID: 35235851
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of the multikinase inhibitor regorafenib in patient-derived xenograft models of gastric cancer.
Huynh H; Ong R; Zopf D
J Exp Clin Cancer Res; 2015 Oct; 34():132. PubMed ID: 26514182
[TBL] [Abstract][Full Text] [Related]
4. Vandetanib versus Cabozantinib in Medullary Thyroid Carcinoma: A Focus on Anti-Angiogenic Effects in Zebrafish Model.
Carra S; Gaudenzi G; Dicitore A; Saronni D; Cantone MC; Plebani A; Ghilardi A; Borghi MO; Hofland LJ; Persani L; Vitale G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809722
[TBL] [Abstract][Full Text] [Related]
5. Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms.
Scott AJ; Arcaroli JJ; Bagby SM; Yahn R; Huber KM; Serkova NJ; Nguyen A; Kim J; Thorburn A; Vogel J; Quackenbush KS; Capasso A; Schreiber A; Blatchford P; Klauck PJ; Pitts TM; Eckhardt SG; Messersmith WA
Mol Cancer Ther; 2018 Oct; 17(10):2112-2122. PubMed ID: 30026382
[TBL] [Abstract][Full Text] [Related]
6. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer.
Wu JQ; Zhai J; Li CY; Tan AM; Wei P; Shen LZ; He MF
J Exp Clin Cancer Res; 2017 Nov; 36(1):160. PubMed ID: 29141689
[TBL] [Abstract][Full Text] [Related]
7. Apatinib inhibits the proliferation of gastric cancer cells via the AKT/GSK signaling pathway
Chen Y; Chen N; Xu J; Wang X; Wei X; Tang C; Duanmu Z; Shi J
Aging (Albany NY); 2021 Aug; 13(16):20738-20747. PubMed ID: 34453028
[TBL] [Abstract][Full Text] [Related]
8. Regorafenib inhibits growth, angiogenesis, and metastasis in a highly aggressive, orthotopic colon cancer model.
Abou-Elkacem L; Arns S; Brix G; Gremse F; Zopf D; Kiessling F; Lederle W
Mol Cancer Ther; 2013 Jul; 12(7):1322-31. PubMed ID: 23619301
[TBL] [Abstract][Full Text] [Related]
9. Comparison of effects of anti-angiogenic agents in the zebrafish efficacy-toxicity model for translational anti-angiogenic drug discovery.
Chimote G; Sreenivasan J; Pawar N; Subramanian J; Sivaramakrishnan H; Sharma S
Drug Des Devel Ther; 2014; 8():1107-23. PubMed ID: 25170251
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic activity of para-coumaric acid methyl ester on HUVECs in vitro and zebrafish in vivo.
Zhang HZ; Li CY; Wu JQ; Wang RX; Wei P; Liu MH; He MF
Phytomedicine; 2018 Sep; 48():10-20. PubMed ID: 30195867
[TBL] [Abstract][Full Text] [Related]
11. Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
Nicoli S; Ribatti D; Cotelli F; Presta M
Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
[TBL] [Abstract][Full Text] [Related]
13. Spatholobi Caulis extracts promote angiogenesis in HUVECs in vitro and in zebrafish embryos in vivo via up-regulation of VEGFRs.
Zhou ZY; Huan LY; Zhao WR; Tang N; Jin Y; Tang JY
J Ethnopharmacol; 2017 Mar; 200():74-83. PubMed ID: 27989880
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer.
Bajbouj K; Qaisar R; Alshura MA; Ibrahim Z; Alebaji MB; Al Ani AW; Janajrah HM; Bilalaga MM; Omara AI; Abou Assaleh RS; Saber-Ayad MM; Elmoselhi AB
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457226
[TBL] [Abstract][Full Text] [Related]
15. Pro-angiogenic activity of isoliquiritin on HUVECs in vitro and zebrafish in vivo through Raf/MEK signaling pathway.
Zhang XH; Li CY; Lin QH; He ZH; Feng F; He MF
Life Sci; 2019 Apr; 223():128-136. PubMed ID: 30876941
[TBL] [Abstract][Full Text] [Related]
16. Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograftzebrafish model.
Jin Y; Wei L; Jiang Q; Song X; Teng C; Fan C; Lv Y; Liu Y; Shen W; Li L; Huang D; Xin T
Sci Rep; 2018 Oct; 8(1):15837. PubMed ID: 30367145
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and apatinib: a new hope for patients with advanced gastric cancer?
de Mello RA; de Oliveira J; Antoniou G
Future Oncol; 2017 Feb; 13(4):295-298. PubMed ID: 27928929
[No Abstract] [Full Text] [Related]
18. Anti-angiogenic therapies for gastric cancer.
Hironaka S
Asia Pac J Clin Oncol; 2019 Aug; 15(4):208-217. PubMed ID: 31111678
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis inhibitors in early development for gastric cancer.
Pinto MP; Owen GI; Retamal I; Garrido M
Expert Opin Investig Drugs; 2017 Sep; 26(9):1007-1017. PubMed ID: 28770623
[TBL] [Abstract][Full Text] [Related]
20. Preclinical comparison of regorafenib and sorafenib efficacy for hepatocellular carcinoma using multimodality molecular imaging.
Liu S; Du Y; Ma H; Liang Q; Zhu X; Tian J
Cancer Lett; 2019 Jul; 453():74-83. PubMed ID: 30928380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]